1,7-Dihydroxy-3,4-Dimethoxyxanthone Inhibits Lipopolysaccharide-Induced Inflammation in RAW264.7 Macrophages by Suppressing TLR4/NF-κB Signaling Cascades
- 29 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Inflammation
- Vol. 43 (5), 1821-1831
- https://doi.org/10.1007/s10753-020-01256-3
Abstract
Securidaca inappendiculata Hassk. is a traditional Chinese anti-rheumatic herbal medicine native to southern China. In this study, we identified a possible TLR4 inhibitor from this plant. General effects of its xanthone-rich fraction (XRF) on inflammation in vitro were investigated by immunoblotting experiments performed on lipopolysaccharides (LPS)-treated RAW264.7 cells, and the possible ligand of TLR4 within was screened out by analyzing chemical composition differences of the XRF containing cell culture medium under different inflammatory circumstances. The interaction between ligand and TLR4 was validated by cellular thermal shift assay (CETSA) and molecular docking simulation, and TLR4/NF-κB pathway status was investigated by immunoprecipitation, ELISA, immunofluorescence, dual-luciferase reporter, and immunoblotting experiments. Treatment with XRF resulted in significant decrease in p-p65 and p-JNK, and the signal accounting for 1,7-dihydroxy-3,4-dimethoxyxanthone (XAN) at 12.5 min with mass of 289.29 was greatly decreased in XRF containing medium after LPS stimulus because of enhanced interaction with increased TLR4. CETSA and molecular docking simulation demonstrated that XAN could bind to TLR4 directly on a smooth region adjacent to its contact interface with MD-2. XAN treatment inhibited the dimerization of TLR4 and transcriptional activity of NF-κB in HEK293T cells and decreased p65 accumulation in nucleus and pro-inflammatory cytokines production in RAW264.7 cells receiving LPS treatment. Overall evidences suggest that XAN could be a selective TLR4 inhibitor with potent anti-inflammatory effects. Also, it indicated that xanthone derivatives could have promising clinical application in many immune-mediated inflammations by acting as TLR4 inhibitors.Keywords
Funding Information
- National Natural Science Foundation of China (81603388 and 81973823)
- Talent Cultivation and International Academic Visiting Project for College Scholar of Anhui Province (gxfxZD2016163)
This publication has 31 references indexed in Scilit:
- Xanthones from Securidaca inappendiculata Exert Significant Therapeutic Efficacy on Adjuvant-Induced Arthritis in MiceInflammation, 2014
- Xanthones asα-glucosidase inhibitors from the antihyperglycemic extract ofSecuridaca inappendiculataPharmaceutical Biology, 2014
- TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2013
- The Role of Different Subsets of Regulatory T Cells in Immunopathogenesis of Rheumatoid ArthritisArthritis, 2012
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- Structural Biology of the Toll-Like Receptor FamilyAnnual Review of Biochemistry, 2011
- Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T CellsArchivum Immunologiae et Therapiae Experimentalis, 2010
- Innate immunity, epigenetics and autoimmunity in rheumatoid arthritisMolecular Immunology, 2009
- Macrophages and their products in rheumatoid arthritisCurrent Opinion in Rheumatology, 2007
- VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblastsRheumatology, 2005